Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

XtalPi and the University of Hong Kong's Advanced Biomedical Instrumentation Centre Establish Collaboration to Accelerate Deep Tech Commercialization

Monday, November 27, 2023

XtalPi Inc and the Advanced Biomedical Instrumentation Centre at the University of Hong Kong have established a memorandum of understanding

Innovent Announces Acceptance and Priority Review Designation for IBI351 New Drug Application by China's National Medical Products Administration

Friday, November 24, 2023

Innovent Biologics Inc has made a significant announcement regarding the acceptance of the New Drug Application for IBI a KRAS GC inhibitor by the Center for Drug Evaluation of the National Medical Products

Ark Biopharmaceutical's AK0610 Receives IND Approval for RSV Antibody

Friday, November 24, 2023

Shanghai Ark Biopharmaceutical Co Ltd has officially announced the approval of its Investigational New Drug application by the National Medical Products Administration for the innovative antibody drug AK This revolutionary antibody drug

Eirgenix's Breast Cancer Biosimilar Secures Marketing Authorization From the European Commission

Thursday, November 23, 2023

EirGenix Inc has recently announced that the European Commission has granted marketing authorization for EG its trastuzumab biosimilar medicine This biosimilar with plans for commercialization by Sandoz

XtalPi and EDDC Announce a Fresh Collaboration to Fuel Biomedical Advancements with the Integration of Robotics and Advanced Language Models

Thursday, November 23, 2023

Today XtalPi announced a Memorandum of Understanding with the Experimental Drug Development Centre Singapores national drug discovery and development platform hosted by ASTAR

Senhwa Biosciences Granted FDA Approval for Silmitasertib Phase II Study in Viral CAP

Wednesday, November 22, 2023

Senhwa Biosciences Inc has disclosed that its Phase II Investigational New Drug IND application for Silmitasertib has been approved by the US Food and Drug Administration This phase focuses

Connect Biopharma and Simcere Forge Exclusive Licensing and Collaboration Deal in Greater China

Wednesday, November 22, 2023

Connect Biopharma Holdings Limited recently announced that its subsidiaries Connect Biopharma Hong Kong Limited and Suzhou Connect Biopharma Co Ltd have entered into an exclusive license and collaboration

Bioforum Enhances Clinical Trial Technology and Services With Validify Acquisition

Tuesday, November 21, 2023

Bioforum a datafocused technologydriven Contract Research Organization has recently completed the acquisition of Validify a leading player in computer systems validation

Porton Advanced and Ascle Therapeutics Have Established a Strategic Partnership to Enhance the Utilization of NK Cells in Cancer Prevention, Beauty, and Anti-aging

Tuesday, November 21, 2023

Porton Advanced and Ascle Therapeutics have recently announced a strategic partnership focusing on joint efforts in the development and production of NK cells The collaboration extends to advancing innovation

Chiesi Group and Haisco Pharmaceutical Collaborate on New Bronchiectasis Treatment

Monday, November 20, 2023

Chiesi Farmaceutici SpA also known as Chiesi Group a global biopharmaceuticals and healthcare organization with a focus on research has entered into a Licensing Agreement